Hims & Hers Health, Inc.’s (HIMS) investors have been experiencing some short-term losses from the stock of late, since mid-February, as the San Francisco, CA-based health and wellness platform’s stock has faced certain challenges. Although HIMS has lost 3.1% in the last three months, the stock has outperformed the industry’s 12.2% decline. It has also outperformed the broader Medical sector and S&P 500’s 10.9% and 3.8% declines, respectively.A major development of HIMS in recent months has included the lon ...